9 articles, transcripts, and reports
Executive Summary Viking Therapeutics remains entirely devoid of commercialized products and generates zero revenue, making its valuation highly dependent on...
Viking Therapeutics, inc (NASDAQ: VKTX) Q2 2022 Earnings Conference
Viking Therapeutics, inc (NASDAQ: VKTX) Q1 2022 Earnings Conference
Viking Therapeutics, inc (NASDAQ: VKTX) Q4 2021 Earnings Conference
Viking Therapeutics, inc (NASDAQ: VKTX) Q3 2021 Earnings Conference
Viking Therapeutics, inc (NASDAQ: VKTX) Q2 2021 Earnings Conference
Viking Therapeutics Inc (VKTX) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Stephanie Diaz — Manager, Investor Relations Brian Lian — President and Chief Executive Officer Greg…
Viking Therapeutics Inc (NASDAQ: VKTX) Q4 2019 Earnings Conference Call February 26, 2020 Corporate Participants: Stephanie C. Diaz — President and Chief Executive Officer Brian Lian — President and Chief…
— Viking Therapeutics Inc. (NASDAQ: VKTX) reported Q3 2019 loss of $0.08 per share, vs. a loss of $0.13 expected. — Net loss amounted to…
